Sugi Predict

Sugi Predict / Compounds / SCHEMBL10116458

SCHEMBL10116458

SCHEMBL10116458

CC(C)S(=O)(=O)Nc1ccc(C(=O)Nc2ccccc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIA4 P48058 2/20 0.60
▸ GRIA2 P42262 1/20 0.60
▸ KMT2A Q03164 6/20 0.57
▸ MEN1 O00255 5/20 0.57
▸ KDM4E B2RXH2 4/20 0.57
▸ LMNA P02545 3/20 0.57
▸ PTPN1 P18031 2/20 0.57
▸ NPC1 O15118 2/20 0.56
▸ RAB9A P51151 2/20 0.56
▸ ALDH1A1 P00352 2/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ HTT P42858 1/20 0.56
▸ CACNA1B Q00975 1/20 0.55
▸ APBA1 Q02410 1/20 0.55
▸ POLB P06746 2/20 0.55
▸ CTDSP1 Q9GZU7 1/20 0.55
▸ TDP1 Q9NUW8 1/20 0.55
▸ HPGD P15428 1/20 0.55
▸ SIRT1 Q96EB6 1/20 0.54
▸ HDAC2 Q92769 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2562502 0.95 GRIA4 (0.65) GRIA4GRIA2KMT2AMEN1KDM4E
SCHEMBL10116520 0.93 RAB9A (0.67) GRIA4GRIA2KMT2AMEN1KDM4E
SCHEMBL10116577 0.93 GRIA4 (0.62) GRIA4GRIA2KMT2AMEN1KDM4E
SCHEMBL10116542 0.90 KMT2A (0.74) GRIA4GRIA2KMT2AMEN1KDM4E
SCHEMBL10116517 0.88 GRIA4 (0.52) GRIA4GRIA2KMT2AMEN1KDM4E
SCHEMBL10116460 0.88 NPC1 (0.67) GRIA4GRIA2KMT2AMEN1KDM4E
SCHEMBL10116526 0.88 KDM4E (0.74) GRIA4GRIA2KMT2AMEN1KDM4E
SCHEMBL10116627 0.87 LMNA (0.56) GRIA4GRIA2KMT2AMEN1KDM4E
SCHEMBL10802804 0.87 KDM4E (0.56) GRIA4GRIA2KMT2AMEN1KDM4E
SCHEMBL10116464 0.87 LMNA (0.76) GRIA4GRIA2KDM4ELMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-20110039802-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2011-02-17 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015762-A1 NPY Y5 antagonist NPY5R, NPY1R, NPY2R GRIA4 371/4885GRIA2 347/4885KMT2A 2912/4885
US-20100292500-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R GRIA4 335/4885GRIA2 334/4885KMT2A 2768/4885
US-20110039802-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R GRIA4 372/4885GRIA2 358/4885KMT2A 2953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.